Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society

Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society

Abstract Background There is a lack of recent data reflecting the actual use of sodium-glucose cotransporter-2 (SGLT2) inhibitors for heart failure (HF) and type 2 diabetes (DM) in the superaged society. The present study investigated the association between the use of SGLT2 inhibitors and one-year...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Michikazu Nakai, Yoshitaka Iwanaga, Koshiro Kanaoka, Yoko Sumita, Yuichi Nishioka, Tomoya Myojin, Shinichiro Kubo, Katsuki Okada, Tsunenari Soeda, Tatsuya Noda, Yasushi Sakata, Tomoaki Imamura, Yoshihiko Saito, Satoshi Yasuda, Yoshihiro Miyamoto
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: BMC 2022-08-01
Ráidu:Cardiovascular Diabetology
Fáttát:
Diabetes mellitus
Nationwide Electric Health Database
One-year prognosis
An SGLT2 inhibitor
Superaged society 
Liŋkkat:https://doi.org/10.1186/s12933-022-01586-6

Interneahtta

https://doi.org/10.1186/s12933-022-01586-6

Geahča maid